Clinical trial
Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis
NCT07245667 is registered in ClinicalTrials.gov with Propedix, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis
- Lead sponsor
- Propedix, Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 30, 2024
- Completion date
- February 28, 2026
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.